Erik Nerpin
Chairman
Born year: 1961
Member of the board since: 2022
Background: Bachelor of Laws from Uppsala University and Master of Laws at Boston University. Lawyer and founder of Advokatfirman Nerpin AB. Specialized in business administration, corporate governance and stock exchange issues.
Ongoing assignments: Chairman of Kancera AB, Blasieholmen Investment Group Equity AB (publ), Ardazaei Holding AB (publ), edyoutec AB (publ) and Hilbert Group AB (publ). Board member of Diamyd Medical Limited company, EffNet AB, Blasieholmen Investment Group AB, Eurasia Fintech AB, Advokatfirman Nerpin AB, Kancera Management AB, Live Entertainment Group Nordic AB, Sallisac AB and Effnetplattformen Holding AB.
Previous assignments (last 5 years): Chairman of Pila Pharma AB. Board member of Freemelt Holding AB (publ), Krall Entertainment AB, Nenarg AB, Hudya AB, Effnetplattformen AB and Identity Devices Sweden Holding AB.
Holding in Neovici: 275 000 B shares.
Independent in relation to the company and main owners: Yes
